{"id":"https://openalex.org/W4407976286","doi":"https://doi.org/10.1016/j.jtct.2025.01.319","title":"Lisocabtagene Maraleucel (liso-cel) in Patients (Pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from the Final Analysis of the MCL Cohort of the Open-Label, Phase 1, Seamless Design, Multicenter Transcend NHL 001 (TRANSCEND) Study","display_name":"Lisocabtagene Maraleucel (liso-cel) in Patients (Pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from the Final Analysis of the MCL Cohort of the Open-Label, Phase 1, Seamless Design, Multicenter Transcend NHL 001 (TRANSCEND) Study","publication_year":2025,"publication_date":"2025-02-01","ids":{"openalex":"https://openalex.org/W4407976286","doi":"https://doi.org/10.1016/j.jtct.2025.01.319"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtct.2025.01.319","doi":"https://doi.org/10.1016/j.jtct.2025.01.319","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.319","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jtct.2025.01.319","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100438316","display_name":"Michael L. Wang","orcid":"https://orcid.org/0000-0001-9748-5486","observed_orcids":["https://orcid.org/0000-0001-9748-5486"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Wang","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA","The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005565037","display_name":"Tanya Siddiqi","orcid":"https://orcid.org/0000-0001-5292-8298","observed_orcids":["https://orcid.org/0000-0001-5292-8298"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanya Siddiqi","raw_affiliation_strings":["City of Hope National Medical Center, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope National Medical Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010130956","display_name":"Leo I. Gordon","orcid":"https://orcid.org/0000-0003-1666-7064","observed_orcids":["https://orcid.org/0000-0003-1666-7064"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leo I. Gordon","raw_affiliation_strings":["Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000537427","display_name":"Manali Kirtikumar Kamdar","orcid":"https://orcid.org/0000-0002-1930-152X","observed_orcids":["https://orcid.org/0000-0002-1930-152X"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manali Kamdar","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088179815","display_name":"Matthew Alexander Lunning","orcid":"https://orcid.org/0000-0002-2761-7612","observed_orcids":["https://orcid.org/0000-0002-2761-7612"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Lunning","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043131622","display_name":"Alexandre V. Vinaud Hirayama","orcid":"https://orcid.org/0000-0001-7980-3882","observed_orcids":["https://orcid.org/0000-0001-7980-3882"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre V. Hirayama","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002103749","display_name":"Jeremy S. Abramson","orcid":"https://orcid.org/0000-0001-8467-9257","observed_orcids":["https://orcid.org/0000-0001-8467-9257"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy S. Abramson","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016770040","display_name":"Jon E. Arnason","orcid":"https://orcid.org/0000-0001-9038-7277","observed_orcids":["https://orcid.org/0000-0001-9038-7277"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon Arnason","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074766331","display_name":"Nilanjan Ghosh","orcid":"https://orcid.org/0000-0002-3848-6136","observed_orcids":["https://orcid.org/0000-0002-3848-6136","https://orcid.org/0000-0002-7217-243X"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nilanjan Ghosh","raw_affiliation_strings":["Atrium Health, Levine Cancer Institute, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health, Levine Cancer Institute, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030631799","display_name":"Amitkumar Mehta","orcid":"https://orcid.org/0000-0003-0537-4207","observed_orcids":["https://orcid.org/0000-0003-0537-4207"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amitkumar Mehta","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068715900","display_name":"Charalambos Babis Andreadis","orcid":"https://orcid.org/0000-0003-4681-6227","observed_orcids":["https://orcid.org/0000-0003-4681-6227"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charalambos Andreadis","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006999192","display_name":"Scott R. Solomon","orcid":"https://orcid.org/0000-0003-2061-8126","observed_orcids":["https://orcid.org/0000-0003-2061-8126"]},"institutions":[{"id":"https://openalex.org/I101890099","display_name":"Northside Hospital","ror":"https://ror.org/01g63ab19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I101890099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott R. Solomon","raw_affiliation_strings":["Northside Hospital Cancer Institute, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northside Hospital Cancer Institute, Atlanta, GA","institution_ids":["https://openalex.org/I101890099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013424590","display_name":"Giovanna Andreola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47396830","display_name":"Bristol-Myers Squibb (Switzerland)","ror":"https://ror.org/02xqc6638","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I47396830"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Giovanna Andreola","raw_affiliation_strings":["Bristol Myers Squibb, Boudry, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Boudry, Switzerland","institution_ids":["https://openalex.org/I47396830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113114253","display_name":"Ashvin Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashvin Singh","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jing Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052659722","display_name":"Maria Lia Palomba","orcid":"https://orcid.org/0000-0001-5099-9156","observed_orcids":["https://orcid.org/0000-0001-5099-9156"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Lia Palomba","raw_affiliation_strings":["Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5100438316"],"corresponding_institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210091812"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":1.6591,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.83458061,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"31","issue":"2","first_page":"S207","last_page":"S207"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisocabtagene-maraleucel","display_name":"lisocabtagene maraleucel","score":0.9760000109672546},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.8880000114440918},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9409999847412109},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.4959999918937683},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7279999852180481},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9520000219345093},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.6830000281333923},{"id":"https://openalex.org/keywords/neurological-events","display_name":"neurological events","score":0.6700000166893005},{"id":"https://openalex.org/keywords/infection","display_name":"infection","score":0.6179999709129333},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7910000085830688},{"id":"https://openalex.org/keywords/btk-inhibitor-resistance","display_name":"BTK inhibitor resistance","score":0.4090000092983246},{"id":"https://openalex.org/keywords/durable-response","display_name":"durable response","score":0.32600000500679016},{"id":"https://openalex.org/keywords/independent-review-committee","display_name":"independent review committee","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.8005382418632507},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6464586853981018},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.6237030625343323},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.523811936378479},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42445695400238037},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.410684734582901},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39066606760025024},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.33777138590812683},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1764744520187378},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.12392809987068176},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.06259885430335999}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jtct.2025.01.319","doi":"https://doi.org/10.1016/j.jtct.2025.01.319","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.319","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jtct.2025.01.319","doi":"https://doi.org/10.1016/j.jtct.2025.01.319","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.319","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389527245","https://openalex.org/W7204732048","https://openalex.org/W4400109288","https://openalex.org/W2954529696","https://openalex.org/W4386332213","https://openalex.org/W7162542774","https://openalex.org/W4405047973","https://openalex.org/W4380081053","https://openalex.org/W7204719248","https://openalex.org/W3095832065"],"abstract_inverted_index":{"Introduction":[0],"At":[1],"the":[2,7,50,92,99,107,157,174,191,231,238,259,303,328,332,339,369,399,402,436,450,454,464,480],"primary":[3,387],"analysis":[4,52,452],"(PA)":[5],"of":[6,25,33,58,125,185,223,351,372,453,488,500],"TRANSCEND":[8,100,111,455],"(NCT02631044)":[9],"MCL":[10,79,101,112,119,456,494],"cohort,":[11,457],"liso-cel":[12,264,489],"showed":[13],"high":[14,272],"efficacy":[15,51,273,458],"(ORR,":[16,274],"83%;":[17,275],"CR":[18,276],"rate,":[19,277],"72%)":[20,278],"at":[21,166,237],"a":[22,198],"median":[23],"follow-up":[24,201,250],"16.1":[26],"mo,":[27],"with":[28,77,116,163,181,270,286,323,338,341,398,463,466,492],"durable":[29,280],"responses":[30,281,468],"(median":[31,282],"duration":[32],"response":[34],"[DOR],":[35],"15.7":[36],"mo)":[37,43,48,285,291,296],"and":[38,44,55,72,135,142,207,279,292,353,390,396,459,472,484],"sustained":[39,287,481],"PFS":[40,288],"(median,":[41,46,289,294],"15.3":[42],"OS":[45,208,293],"18.2":[47],"in":[49,75,156,173,197,302,331,490],"set":[53,334],"(EAS)":[54],"low":[56,395],"rates":[57],"grade":[59],"(gr)":[60],"\u2265":[61,121,182,355,375,379,383,420,496],"3":[62,356,376,380,384],"cytokine":[63],"release":[64],"syndrome":[65,441],"(CRS;":[66],"1%),":[67],"neurological":[68],"events":[69],"(NE;":[70],"9%),":[71],"infections":[73],"(15%)":[74],"pts":[76,97,162,180,193,225,229,235,244,307,415,427,491],"R/R":[78,493],"(Wang":[80],"M,":[81],"et":[82],"al.":[83],"J":[84],"Clin":[85],"Oncol":[86],"2024).":[87],"Objectives":[88],"Report":[89],"results":[90],"from":[91,98,368],"final":[93,451],"analysis,":[94],"when":[95],"all":[96,179],"cohort":[102,113],"had":[103,416,429],"completed":[104,230],"or":[105,189,240],"discontinued":[106,241],"study.":[108],"Methods":[109],"The":[110],"enrolled":[114,246],"adults":[115],"R/R,":[117],"PET-positive":[118,164],"after":[120,214,313,363,408,495],"2":[122,348,497],"prior":[123,498],"lines":[124,499],"systemic":[126,501],"therapy":[127],"including":[128,251,431,503],"Bruton":[129],"tyrosine":[130],"kinase":[131],"inhibitor":[132],"(BTKi),":[133],"alkylating,":[134],"CD20-targeted":[136],"agents.":[137],"Primary":[138],"endpoints":[139],"included":[140],"AEs":[141,365,418],"ORR":[143],"by":[144],"independent":[145],"review":[146],"committee":[147],"(IRC)":[148],"per":[149,168],"Lugano":[150],"2014":[151],"criteria.":[152],"Efficacy":[153],"is":[154,171],"reported":[155,172],"EAS,":[158],"defined":[159,177],"as":[160,178,301],"liso-cel\u2013treated":[161,175,333],"disease":[165],"baseline":[167],"IRC.":[169],"Safety":[170,330],"set,":[176],"1":[183,299,432],"dose":[184],"liso-cel.":[186,215,227],"After":[187],"completing":[188],"discontinuing":[190],"study,":[192],"were":[194,366,461],"to":[195,211,247,266,318,445],"enroll":[196],"separate":[199],"long-term":[200],"(LTFU)":[202],"study":[203,232],"(NCT03435796)":[204],"assessing":[205],"safety":[206,344,460,475],"for":[209],"up":[210],"15":[212],"y":[213],"Results":[216,220],"are":[217],"summarized":[218],"descriptively.":[219],"A":[221],"total":[222],"88":[224],"received":[226],"All":[228],"(including":[233],"10":[234],"ongoing":[236],"PA)":[239],"earlier;":[242],"29":[243],"have":[245],"LTFU.":[248],"Median":[249],"LTFU":[252],"was":[253,335],"19.5":[254],"mo":[255],"(range,":[256],"0.4\u201372.0).":[257],"In":[258,401,449],"EAS":[260],"(n":[261,308,320],"=":[262,309,321,411,423],"83),":[263],"continued":[265,467],"show":[267],"clinical":[268,482],"benefit,":[269],"consistently":[271],"DOR,":[283,470],"14.5":[284],"12.3":[290],"18.4":[295],"(":[297,346],"Table":[298,347],"),":[300],"PA.":[304,329,370,400],"Among":[305],"leukapheresed":[306],"104),":[310],"48":[311],"died":[312],"product":[314],"infusion,":[315],"mostly":[316],"due":[317],"PD":[319],"31)":[322],"no":[324,342,473],"new":[325,343,474],"deaths":[326],"since":[327,435],"also":[336,393],"consistent":[337,397,462],"PA,":[340],"signals":[345],").":[349],"Rates":[350,371],"any-gr":[352,417],"gr":[354,374,378,382],"treatment-emergent":[357],"(TE;":[358],"occurring":[359],"\u2264":[360],"90":[361,406],"d":[362,407],"liso-cel)":[364],"unchanged":[367],"TE":[373],"CRS,":[377],"NEs,":[381],"infections,":[385],"second":[386],"malignancies":[388],"(SPM),":[389],"prolonged":[391],"cytopenias":[392],"remained":[394],"post-TE":[403],"period":[404],"(>":[405],"liso-cel;":[409],"n":[410,422],"82),":[412],"45":[413],"(55%)":[414],"(gr":[419],"3,":[421],"25":[424],"[30%]);":[425],"14":[426],"(17%)":[428],"SPMs,":[430],"additional":[433],"pt":[434],"PA":[437,465],"who":[438],"developed":[439],"myelodysplastic":[440],",":[442],"considered":[443],"related":[444],"lymphodepleting":[446],"chemotherapy.":[447],"Conclusion":[448],"(24-mo":[469],"42%)":[471],"signals.":[476],"These":[477],"data":[478],"support":[479],"benefit":[483],"favorable":[485],"benefit/risk":[486],"profile":[487],"therapy,":[502],"BTKi.":[504]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-02-27T00:00:00"}